Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Medical Virology"
DOI: 10.1002/jmv.25745
Abstract: This study aims to evaluate the clinical effectiveness in terms of sustained virological response (SVR), predictors of SVR and safety of available second‐generation generic direct‐acting antivirals in Pakistani chronic hepatitis C patients. This is a… read more here.
Keywords: daclatasvir; treatment; genotype; direct acting ... See more keywords
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2017.1360313
Abstract: We acknowledge that older data were used in our model, which can be explained by the fact that we finalized the model inputs before the 2014 CDC statistics were published. The updated age and sex… read more here.
Keywords: daclatasvir; daclatasvir sofosbuvir; reply cost; cost effectiveness ... See more keywords
Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2145883
Abstract: ABSTRACT Introduction Globally, it is estimated that 290,000 patients infected with hepatitis C virus (HCV) died from hepatitis C consequences, including cirrhosis and hepatocellular carcinoma in 2019. Although daclatasvir (DCV), combined with sofosbuvir (SOF), is… read more here.
Keywords: treatment option; daclatasvir; hcv; hepatitis ... See more keywords
Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13321
Abstract: Sofosbuvir plus daclatasvir with or without ribavirin has demonstrated a high efficacy and an acceptable safety profile in clinical trials of patients infected with genotype 2 hepatitis Cvirus (HCV); however, there are currently no real‐world… read more here.
Keywords: without ribavirin; daclatasvir; sofosbuvir daclatasvir; daclatasvir without ... See more keywords
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
Sign Up to like & getrecommendations! Published in 2017 at "Liver International"
DOI: 10.1111/liv.13383
Abstract: Optimally effective treatment for hepatitis C virus genotype 3 (GT3) is urgently needed, particularly in advanced liver disease. Daclatasvir plus sofosbuvir was efficacious in phase 3 studies. Real‐world data for daclatasvir+sofosbuvir in advanced GT3 infection… read more here.
Keywords: daclatasvir; daclatasvir plus; plus sofosbuvir; hepatitis virus ... See more keywords
Efficacy and safety of daclatasvir‐based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Sign Up to like & getrecommendations! Published in 2017 at "Transplant International"
DOI: 10.1111/tri.12999
Abstract: Direct‐acting antiviral agents (DAA) combining daclatasvir (DCV) have reported good outcomes in the recurrence of hepatitis C virus (HCV) infection after liver transplant (LT). However, its effect on the severe recurrence and the risk of… read more here.
Keywords: therapy; daclatasvir; hepatitis virus; liver ... See more keywords
Development and Validation of HPLC Fluorescence and UPLC/DAD Stability-Indicating Methods for Determination of Hepatitis C Antiviral Agent Daclatasvir.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of AOAC International"
DOI: 10.5740/jaoacint.18-0344
Abstract: Background: Few stability-indicating chromatographic methods were published for determination of daclatasvir. All used UV detection. Objective: This work aimed to develop rapid, specific, and novel stability-indicating methods using HPLC with fluorescence detection and ultra performance… read more here.
Keywords: daclatasvir; detection; fluorescence; determination ... See more keywords